about
The Alzheimer's Prevention Clinic at Weill Cornell Medical College / New York - Presbyterian Hospital: Risk Stratification and Personalized Early Intervention.RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.Immune aging, dysmetabolism, and inflammation in neurological diseases.Farnesylated and methylated KRAS4b: high yield production of protein suitable for biophysical studies of prenylated protein-lipid interactions.Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men.Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer's Disease and Vascular Dementia: A Cross-Sectional Study.Advances in high-density lipoprotein physiology: surprises, overturns, and promises.Association Studies of Specific Cholesterol Related Genes (APOE, LPL, and CETP) with Lipid Profile and Memory Function: A Correlative Study Among Rural and Tribal Population of Dharmapuri District, India.Sex-dependent difference in the relationship between adipose-tissue cholesterol efflux and estradiol concentrations in young healthy humans.ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance.Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.White matter microstructure and cognitive decline in metabolic syndrome: A review of diffusion tensor imaging.27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation.Lipopolysaccharide enters the rat brain by a lipoprotein-mediated transport mechanism in physiological conditions.Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting.Does apolipoprotein A1 predict microstructural changes in subgenual cingulum in early Parkinson?Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease.Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke.High-Density Lipoprotein Cholesterol Level Relates to Working Memory, Immediate and Delayed Cued Recall in Brazilian Older Adults: The Role of Cognitive Reserve.Lifetime cognition and late midlife blood metabolites: findings from a British birth cohortGenetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease
P2860
Q33697647-356E98AA-3DD6-4F74-B90D-C5EE81659022Q35662879-F6ECEC8D-4804-4DC7-B050-597A7A2F11D1Q35677347-6E283889-0E50-4C0E-95C6-A1D543D08E1BQ36237636-11CA5D28-F41A-4BFE-BF9C-B4D6ECA29E8CQ36349870-05AAF31C-F4CE-4DD0-B4B2-DB64672F6FA0Q37628115-8AEC4DE2-BA90-461B-85D2-192231640B65Q38623588-6C1A3572-6E90-4B60-983E-CAC8C9F09A10Q38640748-662AE286-01A3-4E7A-8309-58DB1E7448C6Q38678391-B4B71572-D6B2-44AC-97FD-BEB06955CC8FQ40736250-8BDAB300-E33D-4969-8112-EAAF0556C473Q40762551-1F46007D-363D-4DFD-AD42-CFCF51A8E88AQ41039610-1D088D6E-1690-4DF4-A2CA-A0F657B34886Q41997088-E7BE0152-46B9-4B38-92DD-685942D83107Q42317971-1056330C-F8F4-4BB4-9513-9D9092C21BF7Q42377215-7E897C6B-3803-4A18-925A-C780F59748E4Q47408666-E14E4C90-FF8E-4CE0-A7A5-3FB556E017AEQ48320628-6FF4FCD5-3E60-4FFA-BED6-8978296F8D57Q49962878-BFBE9593-0650-4690-A707-2C8CD8FDD0FCQ50043011-C76463E2-6E46-4AAE-8312-5639E6BE8617Q50571747-CA1BFC6B-4559-4573-B2DF-7504484BEFDEQ57315662-6571974D-00BB-429D-945C-95AE9E08560CQ58701994-213AC56B-84AD-435F-A590-29145C5DB2BE
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HDL and cognition in neurodegenerative disorders.
@ast
HDL and cognition in neurodegenerative disorders.
@en
HDL and cognition in neurodegenerative disorders.
@nl
type
label
HDL and cognition in neurodegenerative disorders.
@ast
HDL and cognition in neurodegenerative disorders.
@en
HDL and cognition in neurodegenerative disorders.
@nl
prefLabel
HDL and cognition in neurodegenerative disorders.
@ast
HDL and cognition in neurodegenerative disorders.
@en
HDL and cognition in neurodegenerative disorders.
@nl
P2093
P2860
P1476
HDL and cognition in neurodegenerative disorders
@en
P2093
David A Hottman
Dustin Chernick
Shaowu Cheng
P2860
P356
10.1016/J.NBD.2014.07.015
P478
P50
P577
2014-08-13T00:00:00Z